Tatsuo Iijima

1.6k citations
92 papers · 1.2k indexed · h-index 21
Topics
Neuroendocrine Tumor Research Advances (9 papers)Lung Cancer Research Studies (9 papers)RNA modifications and cancer (8 papers)
Partner nations
JapanUnited StatesRussia

In The Last Decade

Tatsuo Iijima

87 papers receiving 1.2k citations

Peers

Tatsuo Iijima
Comparison fields: 5 of 92
  • Molecular Biology 401
  • Pulmonary and Respiratory Medicine 366
  • Oncology 336
  • Surgery 265
  • Cancer Research 191
Replace Makoto Toi with:
Makoto Toi Japan
Pramod Kumar Julka India
Francisco J. Martínez‐Tello Spain
Irshad Soomro United Kingdom
G. Goovaerts Belgium
Hideoki Yokouchi Japan
Takahiko Kasai Japan
Takako Yoshioka Japan
Barry R. DeYoung United States
Ioan Jung Romania
Tatsuo Iijima relative to Makoto Toi Japan Makoto Toi's profile →
Citations per field
00.5×2.5×
Makoto Toi · 1×
Citations per year

Countries citing papers authored by Tatsuo Iijima

Since Specialization
Citations

This map shows the geographic impact of Tatsuo Iijima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tatsuo Iijima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tatsuo Iijima more than expected).

Fields of papers citing papers by Tatsuo Iijima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tatsuo Iijima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tatsuo Iijima. The network helps show where Tatsuo Iijima may publish in the future.

Co-authorship network of co-authors of Tatsuo Iijima

This figure shows the co-authorship network connecting the top 25 collaborators of Tatsuo Iijima. A scholar is included among the top collaborators of Tatsuo Iijima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tatsuo Iijima. Tatsuo Iijima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 13
4 22
5 14
6 13
7 3
8 10
9 18
10 1
11 20
12 22
13 2
14 4
15 8
16 36
17
Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma.
81
18 6
19 16
20 2

About Tatsuo Iijima

Tatsuo Iijima is a scholar working on Oncology, Cancer Research and Hepatology, having authored 92 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (9 papers), Lung Cancer Research Studies (9 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Hepatology (115 citations), Cancer Research (191 citations) and Oncology (336 citations). Tatsuo Iijima has collaborated with scholars based in Japan, United States and Russia. Frequent co-authors include Masayuki Noguchi, Yuko Minami, Yukio Morishita, Junko Kano, Katashi Fukao, Yukinori Inadome, Yoichi Anami, Yasutsugu Takada, Kiyoshi Fukunaga and Kenji Yuzawa. Their work appears in journals such as Blood, Cancer and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026